XTANT MEDICAL HOLDINGS, INC. (XTNT) Return on equity 2020–2025
XTANT MEDICAL HOLDINGS, INC. (XTNT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
9.8%FY2025 · since FY2020: -48.4% → 9.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 9.8% | +48.0 pp |
| FY2024 | -38.3% | -39.6 pp |
| FY2023 | 1.3% | +26.1 pp |
| FY2022 | -24.8% | -9.1 pp |
| FY2021 | -15.7% | +32.7 pp |
| FY2020 | -48.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More XTNT financial trends
XTNT RevenueXTNT Net incomeXTNT Net marginXTNT Gross profitXTNT Gross marginXTNT Operating incomeXTNT Operating marginXTNT Operating cash flowXTNT Free cash flowXTNT Capital expendituresXTNT Stock buybacksXTNT Dividends paidXTNT Total assetsXTNT Total liabilitiesXTNT Shareholders’ equityXTNT overview →